Global Cell Culture Market 2022-2028

Description

List of Tables

Global Cell Culture Market Size, Share & Trends Analysis Report by Product (Equipment And Consumables), and by Application (Biopharmaceuticals Application, Diagnostics, Drug Discovery & Development, Tissue Engineering & Regenerative Medicine, Cancer & Stem Cell Research And Others), and by End-User (Pharmaceutical & Biotechnology Companies And Research Institutes) Forecast Period (2022-2028)

The global cell culture market is anticipated to grow at a substantial CAGR of 10.5% during the forecast period. The steady increase in demand for monoclonal antibodies, rising preference for single-use technologies, and increasing R&D in cell-based research for the development of innovative cell culture equipment further give a boost to the growth of the market. For instance, in August 2021, Amerigo Scientific launched 3D Cell Culture for scientific uses it will use in research areas such as drug discovery, medicine, evaluation of nanomaterials, and basic life science. The newly developed culture allows a greater predictivity of efficacy and toxicity before these drugs move into pre-clinical animal testing.

The global cell culture market is segmented on the basis of product, application, and end-user. On the basis of product, the market is sub-classified into equipment and consumables. Based on application, the market is sub-categorized into biopharmaceuticals application, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, cancer & stem cell research, and others such as toxicology. Moreover, based on end-user, the market is further sub-divided into pharmaceutical & biotechnology companies and research institutes. Among the end-user segment, the pharmaceutical & biotechnology companies sub-segment is dominating due to the expansion of these companies, and growing regulatory approvals for the production and development of cell culture-based vaccines.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is dominated in the global cell culture market attributed to growing government support for drug discovery and development, and rising cancer research within the region. For instance, in January 2020, the Centers for Disease Control and Prevention (CDC) received a specimen collected from the US and generated enough SARS-CoV-2 grown in cell culture and it issued them to medical and scientific researchers. Moreover, the US government is reassuring in terms of medical research as healthcare is one of the major priorities in the region.

The competitive landscape includes key strategies of leading players, recent developments, and key company analysis. The major players that contribute to the growth of the market include Becton, Dickinson, and Co. Corning Inc., Eppendorf AG, General Electric Co., Lonza Group Ltd., Merck KGaA, Thermo Fisher Scientific, Inc., and many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In February 2020, Univercells received up to EUR 50M financing from Gamma Biosciences, supported by firm KKR, that focuses on next-generation bioprocessing technologies for the production of advanced biologic therapies that includes next-generation bioprocessing technologies for the production of advanced biologic therapies.

Research Methodology

The market study of the global cell culture market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.
Whitepapers, research papers, and news blogs.
Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Cell Culture Market Research and Analysis by Product

2. Global Cell Culture Market Research and Analysis by Application

3. Global Cell Culture Market Research and Analysis by End-User

The Report Covers

Comprehensive research methodology of the global cell culture market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global cell culture market.
Insights about market determinants that are stimulating the global cell culture market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2017138

Category- Biotechnology

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Impact of COVID-19 on the Global Cell culture Market
Recovery Scenario of Global Cell culture Market
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Becton, Dickinson, and Co.
- 3.1.1. Overview
- 3.1.2. Financial Analysis
- 3.1.3. SWOT Analysis
- 3.1.4. Recent Developments
3.2. Corning Inc.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Lonza Group Ltd.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Merck KGaA
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Thermo Fisher Scientific, Inc.
- 3.5.1. Overview
- 3.5.2. Financial Analysis
- 3.5.3. SWOT Analysis
- 3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

4.1. Global Cell Culture Market by Product
- 4.1.1. Equipment
- 4.1.2. Consumables
4.2. Global Cell Culture Market by Applicatiion
- 4.2.1. Biopharmaceuticals Application
- 4.2.2. Diagnostics
- 4.2.3. Drug Discovery and Development
- 4.2.4. Tissue Engineering & Regenerative Medicine
- 4.2.5. Cancer and Stem Cell Research
- 4.2.6. Others (Toxicology)
4.3. Global Cell Culture Market by End User
- 4.3.1. Pharmaceutical and Biotechnology Companies
- 4.3.2. Research Institutes

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. 3D Biotek LLC
6.2. 3DHEALS CO.
6.3. Analytical Biological Services, Inc.
6.4. BioIVT
6.5. Biospherix Ltd.
6.6. Cell Essentials, Inc.
6.7. Sartorius CellGenix GmbH
6.8. Wix.com, Inc
6.9. Danaher Corp.
6.10. Eppendorf SE
6.11. Fujifilm Holdings Corp.
6.12. General Electric Co.
6.13. InSphero AG
6.14. InVitria
6.15. InvivoGen
6.16. LGC Clinical Diagnostics, Inc.
6.17. MP Biomedicals, LLC
6.18. Novartis AG
6.19. PerkinElmer Inc.
6.20. Promega Corp.
6.21. PromoCell GmbH
6.22. Sanofi SA
6.23. Sartorius AG
6.24. VWR International, LLC.